Related Experiment Video
Updated: May 14, 2026

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy
Leena Das1, Peter C Blumbergs, Jim Manavis
1*Department of Rheumatology, North Manchester General Hospital, Pennine Acute Hospital NHS Trust, Manchester, UK †Department of Neuropathology, Hanson Institute, Institute of Medical and Veterinary Sciences, Adelaide ‡Department of Rheumatology, Royal Adelaide Hospital §Department of Medicine Adelaide University, Adelaide, Australia.
Introduction:
We sought to study the intensity and pattern of major histocompatibility complex (MHC) I and II expression in muscle from patients with biopsy-proven idiopathic inflammatory myositis (IIM) including the subgroups, polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM).
Methods:
A total of 120 muscle biopsies (61 PM, 14 DM, and 45 IBM) were immunostained for MHC I and II. Staining was graded as follows. 0: no staining, 1+: ≤10% fibers, 2+: 10% to 25%, 3+: 25% to 50%, 4+: 50% to 99%, and 5+ 100%.
Results:
All IIM biopsies showed MHC I positivity; 93% showed MHC II positivity. The proportion of patients with MHC II score ≥3+ was higher in IBM than DM or PM. In DM, MHC I expression showed a perifascicular pattern. All IBM biopsies were immunopositive for MHC I and II; 30/45 were scored 5+.
Discussion:
Immunostaining for MHC I and II is a useful adjunctive test in diagnosis and subclassification of IIM.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Myasthenia Gravis ll: Pathophysiology
Inflammatory Bowel Disease II: Ulcerative Colitis
